UK scaleups to watch: the $250M–$1B cohort heading into 2026
The UK’s startup ecosystem is entering 2026 with a growing middle tier of “almost-unicorns”: companies typically valued between $250 million and $1 billion. These businesses tend to have product-market fit, expanding enterprise or consumer adoption, and a funding profile that includes late Series B through Series D rounds. While headline-grabbing unicorns still dominate attention, this cohort is often where the next wave of category leaders emerges—especially in biotech, AI, fintech, and cleantech.
Below are 10 UK startups and scaleups that fit the “disruptor” profile and are widely viewed by investors as positioned for meaningful growth into 2026. Valuation ranges are indicative, reflecting market comparables, public disclosures where available, and typical pricing for late-stage UK venture rounds.
Biotech: platform science and faster clinical translation
Relation Therapeutics (London)
Relation Therapeutics is part of a new generation of biotech companies combining computational biology with drug discovery. Its platform approach aims to identify novel targets and improve the probability of success in early-stage programs. The company has attracted significant venture backing in recent years, reflecting investor appetite for “AI-native” life sciences. Heading into 2026, progress will be judged by pipeline maturation, partnerships with larger pharma, and the ability to translate platform claims into clinical candidates.
Quell Therapeutics (London)
Quell Therapeutics focuses on engineered regulatory T cells (Tregs), a promising area in immunology that targets autoimmune disease and transplant rejection. Cell therapy remains capital intensive, but scaleups that show manufacturing readiness and early clinical signals can command strong late-stage interest. For 2026, key milestones include clinical readouts, manufacturing scale-up, and potential strategic collaborations.
AI: enterprise adoption, safety, and applied intelligence
Faculty (London)
Faculty has built a reputation for deploying applied AI in business and public-sector settings, with a focus on practical outcomes rather than research novelty. As enterprises increasingly move from pilots to production, service-plus-platform companies like Faculty can benefit from recurring revenue and long-term contracts. The 2026 trajectory hinges on expanding international footprints and productizing repeatable solutions in regulated industries.
Quantexa (London)
Quantexa operates in decision intelligence—using data fusion and analytics to support fraud detection, risk management, and compliance. With financial institutions and governments under pressure to modernize anti-fraud capabilities, Quantexa’s market remains large and sticky. Its path toward 2026 will likely be driven by larger enterprise deployments, expansion into adjacent use cases, and continued investment in explainability and governance.
Fintech: infrastructure, compliance, and embedded finance
Zopa (London)
Zopa has evolved from early peer-to-peer lending roots into a digital bank with consumer credit and savings products. The UK’s rate environment and credit cycle will shape fintech performance through 2026, making underwriting discipline and funding costs critical. Zopa’s growth story depends on balancing customer acquisition with profitability and expanding product breadth without taking on outsized risk.
Rapyd (London)
Rapyd provides payments and fintech-as-a-service infrastructure aimed at enabling embedded finance across markets. Infrastructure fintechs can scale quickly when they win platform clients, but they also face heightened scrutiny around compliance, risk, and cross-border operations. Through 2026, investors will watch for sustainable unit economics, geographic expansion that doesn’t compromise controls, and deeper enterprise penetration.
Thought Machine (London)
Thought Machine builds cloud-native core banking technology, a major modernization target for incumbent banks. Core replacement projects are lengthy but high value, and successful deployments can create durable revenue streams. For 2026, the company’s momentum will be measured by production go-lives, customer references, and the pace at which banks shift from legacy systems to modular architectures.
Cleantech: electrification, grids, and decarbonization at scale
Octopus Energy (London)
Octopus Energy has become a flagship UK cleantech scaleup, spanning retail energy and technology platforms that optimize pricing, demand, and grid interactions. The company’s software-led approach positions it well as electrification accelerates. Into 2026, growth will be tied to international expansion, regulatory developments, and the ability to scale customer operations while maintaining service quality.
Zenobe (London)
Zenobe focuses on battery storage and fleet electrification, including financing and operational support for electric buses and commercial vehicles. As grids integrate more renewables, storage becomes increasingly valuable, but projects demand substantial capital and long-term planning. Zenobe’s 2026 outlook depends on project pipeline execution, access to financing, and grid services revenue stability.
Ovo Energy (Bristol/London)
Ovo Energy has expanded beyond retail supply into services designed to help households manage energy use and costs. The broader market is shaped by policy, wholesale pricing, and consumer sensitivity, but companies that can combine digital experience with demand-side management may benefit as smart tariffs and home electrification grow. For 2026, the focus will be on retention, operational efficiency, and product innovation in home energy management.
What funding and growth signals matter most for 2026
Across sectors, late-stage investors are increasingly selective, prioritizing capital efficiency, clear pathways to profitability, and defensible differentiation. For biotech, that means clinical progress and partner validation. For AI, it means production deployments, governance, and repeatable revenue. For fintech, it means compliance strength and resilient unit economics. For cleantech, it means project execution, financing access, and regulatory alignment.
The UK’s $250M–$1B cohort is also a reminder that the next breakout companies often emerge from sustained execution rather than hype cycles. If these scaleups hit key milestones—commercial traction, clinical readouts, or infrastructure deployments—several could enter 2026 positioned to raise at higher valuations, pursue IPO readiness, or become acquisition targets for global incumbents.
Related
